USTEKINUMAB
ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
USTEKINUMAB (9305R)
9305R
Manner of administration:Injection
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment, Whole body
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment, Face, hand, foot
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: Continuing treatment, Whole body or Continuing treatment, Face, hand, foot - balance
of supply
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment, Whole body
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment, Face, hand, foot
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $789.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Stelara | |||||